Cancer Clinical

Development of a symptom response to treatment questionnaire for patients in follow-up after oesophago-gastrectomy for cancer

Prehabilitation of Patients With Oesophageal Malignancy Undergoing Peri-Operative Treatment (Pre-EMPT): Outcomes From a Prospective Controlled Trial

REsolution of Symptoms afTer Oesophago-gastric cancer REsection delphi (RESTOREd)—standardizing the definition, investigation and management of gastrointestinal symptoms and conditions after surgery

Association of dynamic contrast-enhanced MRI and <sup>18</sup>F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer

📖 Cited 2 times (Semantic Scholar)

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma

📖 Cited 9 times (Semantic Scholar)

Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma

📖 Cited 4 times (Semantic Scholar)

Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom

📖 Cited 24 times (Semantic Scholar)

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population

📖 Cited 7 times (Semantic Scholar)

Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma – A comparison of the FLOT and ‘MAGIC’ regimens

📖 Cited 16 times (Semantic Scholar)

Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery

📖 Cited 7 times (Semantic Scholar)